BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31300448)

  • 21. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast.
    Willis RC; Seegmiller JE
    J Cell Physiol; 1977 Dec; 93(3):375-82. PubMed ID: 22551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model.
    Shelton LM; Huysentruyt LC; Seyfried TN
    Int J Cancer; 2010 Nov; 127(10):2478-85. PubMed ID: 20473919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Vitro Investigation Demonstrates IGFR/VEGFR Receptor Cross Talk and Potential of Combined Inhibition in Pediatric Central Nervous System Atypical Teratoid Rhabdoid Tumors.
    Obaid H; Kannappan S; Gupta M; Ruan Y; Zhang C; Bose P; Narendran A
    Curr Cancer Drug Targets; 2020; 20(4):295-305. PubMed ID: 31713485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of 6-diazo-5-oxo-L-norleucine (DON), a glutamine analogue, on cartilaginous differentiation in mouse limb buds in vitro.
    Aydelotte MB; Kochhar DM
    Differentiation; 1975 Oct; 4(2):73-80. PubMed ID: 1183764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioanalysis of 6-diazo-5-oxo-l-norleucine in plasma and brain by ultra-performance liquid chromatography mass spectrometry.
    Alt J; Potter MC; Rojas C; Slusher BS
    Anal Biochem; 2015 Apr; 474():28-34. PubMed ID: 25584882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting metabolic abnormalities to reverse fibrosis in iatrogenic laryngotracheal stenosis.
    Murphy MK; Motz KM; Ding D; Yin L; Duvvuri M; Feeley M; Hillel AT
    Laryngoscope; 2018 Feb; 128(2):E59-E67. PubMed ID: 28940431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth.
    Hashizume R; Zhang A; Mueller S; Prados MD; Lulla RR; Goldman S; Saratsis AM; Mazar AP; Stegh AH; Cheng SY; Horbinski C; Haas-Kogan DA; Sarkaria JN; Waldman T; James CD
    Neuro Oncol; 2016 Nov; 18(11):1519-1528. PubMed ID: 27370397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological sequelae induced by alphavirus infection of the CNS are attenuated by treatment with the glutamine antagonist 6-diazo-5-oxo-l-norleucine.
    Potter MC; Baxter VK; Mathey RW; Alt J; Rojas C; Griffin DE; Slusher BS
    J Neurovirol; 2015 Apr; 21(2):159-73. PubMed ID: 25645378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 6-DIAZO-5-OXO-L-NORLEUCINE INHIBITION OF ESCHERICHIA COLI.
    COGGIN JH; MARTIN WR
    J Bacteriol; 1965 May; 89(5):1348-53. PubMed ID: 14293024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A redox-responsive prodrug for tumor-targeted glutamine restriction.
    Prange CJ; Sayed NYB; Feng B; Goepfert C; Trujillo DO; Hu X; Tang L
    J Control Release; 2024 Apr; 368():251-264. PubMed ID: 38403173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disulfiram potentiates the anticancer effect of cisplatin in atypical teratoid/rhabdoid tumors (AT/RT).
    Jangra A; Choi SA; Yang J; Koh EJ; Phi JH; Lee JY; Wang KC; Kim SK
    Cancer Lett; 2020 Aug; 486():38-45. PubMed ID: 32428661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug screening with a novel tumor-derived cell line identified alternative therapeutic options for patients with atypical teratoid/rhabdoid tumor.
    Nakano Y; Takadera M; Miyazaki M; Qiao Z; Nakajima K; Noguchi R; Oyama R; Kimura Y; Okuhiro Y; Yamasaki K; Kunihiro N; Fukushima H; Inoue T; Hara J; Ozawa T; Kondo T; Ichimura K
    Hum Cell; 2021 Jan; 34(1):271-278. PubMed ID: 32997328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of orthotopic mouse brain tumor models.
    Rosol M; Harutyunyan I; Xu J; Melendez E; Smbatyan G; Finlay JL; Krieger MD; Gonzalez-Gomez I; Reynolds CP; Nelson MD; Erdreich-Epstein A; Blüml S
    Mol Imaging; 2009; 8(4):199-208. PubMed ID: 19728974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice.
    Ovejera AA; Houchens DP; Catane R; Sheridan MA; Muggia FM
    Cancer Res; 1979 Aug; 39(8):3220-4. PubMed ID: 572261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors.
    Blümel L; Qin N; Berlandi J; Paisana E; Cascão R; Custódia C; Pauck D; Picard D; Langini M; Stühler K; Meyer FD; Göbbels S; Malzkorn B; Liebau MC; Barata JT; Jeibmann A; Kerl K; Erkek S; Kool M; Pfister SM; Johann PD; Frühwald MC; Borkhardt A; Reifenberger G; Faria CC; Fischer U; Hasselblatt M; Bartl J; Remke M
    Cell Death Dis; 2022 Sep; 13(9):806. PubMed ID: 36127323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor.
    Kao CL; Huang PI; Tsai PH; Tsai ML; Lo JF; Lee YY; Chen YJ; Chen YW; Chiou SH
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):219-28. PubMed ID: 19362240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma.
    Hanaford AR; Alt J; Rais R; Wang SZ; Kaur H; Thorek DLJ; Eberhart CG; Slusher BS; Martin AM; Raabe EH
    Transl Oncol; 2019 Oct; 12(10):1314-1322. PubMed ID: 31340195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity.
    Kaur H; Hütt-Cabezas M; Weingart MF; Xu J; Kuwahara Y; Erdreich-Epstein A; Weissman BE; Eberhart CG; Raabe EH
    J Neuropathol Exp Neurol; 2015 Feb; 74(2):177-85. PubMed ID: 25575139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transport and membrane binding of the glutamine analogue 6-diazo-5-oxo-L-norleucine (DON) in Xenopus laevis oocytes.
    Taylor PM; Mackenzie B; Hundal HS; Robertson E; Rennie MJ
    J Membr Biol; 1992 Jun; 128(3):181-91. PubMed ID: 1501246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mechanism behind the antitumour effect of 6-diazo-5-oxo-L-norleucine (DON): disruption of mitochondria.
    Wu F; Lukinius A; Bergström M; Eriksson B; Watanabe Y; Långström B
    Eur J Cancer; 1999 Jul; 35(7):1155-61. PubMed ID: 10533463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.